Chemoprophylatic. Ayurvedic, Homeopathic and Unani approaches for COVID-19 prophylaxis
Authors
Abstract:
There are no specific therapies approved by the U.S. FDA for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 COVID-19. Several agents are under clinical trial and the use of pharmacological agents are based on in vitro activity against SARS-CoV-2 or related viruses. While the efficacy of drug therapy is yet to be established, we need to focus on prophylactic measures. The current write up describes the chemoprophylactic, ayurvedic, homeopathic and unani prophylactic approaches for combating COVID-19.
similar resources
The Bengal Ayurvedic and Unani Committees
mittees are already in the hands of the Government of Bengal and may shortly be published. Each of the two Committees was composed of ;?(a) several practitioners of the system' of medicine which was under consideration; (;??) several practitioners of scientific medicine; and (c) some representative laymen. We hope shortly to be able to comment on the reports themselves, but in view of the inter...
full textAyurvedic Drugs in Unani Materia Medica
Nearly two hundred Ayurvedic drugs of plant origin have bee introduced in he Unani material medica, the names of most of the drugs have been adopted from Indian languages per se.
full textApproaches for Covid-19 infection control in the workplaces
Introduction: Due to the spread of the new coronavirus around the world, workplaces are not safe against this disease. Different guidelines have been promoted by international organizations regarding high-risk jobs and the necessity of implementing health rules in the workplaces. According to the considerable number of incidence of this disease in our country, the aim of this review article is ...
full textCOVID-19 pandemic: Challenges and approaches in blood transfusions
One of the goals of the Iranian Blood Transfusion Organization is to provide adequate healthy blood and reduce the risk of various viral and bacterial transmission infections. With the removal of alternative blood donation, all blood units and blood products are provided through voluntary blood donation in Iran. The Blood Transfusion Organization screens the donated blood according to standard ...
full textHydroxychloroquine: A bridge prophylaxis till finding the COVID-19 vaccine
Regarding the importance of COVID-19 pandemic and risks that the infection imposes on healthcare workers, this manuscript discusses the potential usage of Hydroxychloroquine as a prophylactic agent.
full textInvasive Aspergillosis in COVID-19: A Review Study and Recommendations for Diagnostic Approaches
Background and purpose: COVID-19 is an emerging viral disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Bacterial or fungal superinfections of the lung may cause complications in clinical manifestations, treatment, and increase the mortality rate. In this article, we reviewed previous studies on invasive aspergillosis (IA) in viral infections and in adjustment with...
full textMy Resources
Journal title
volume 6 issue Special Issue 2 on COVID-19
pages 0- 0
publication date 2020-10
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023